Masashi Yokoya

Meiji Pharmaceutical University

H指数:18

被引数:1,175

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A luciferase-based high-throughput three-dimensional tumor spheroid model identifies a renieramycin T derivative with anti-cancer stem cell activity in non-small cell lung cancer

基于荧光素酶的高通量三维肿瘤球模型鉴定出一种具有抗非小细胞肺癌癌症干细胞活性的雷尼酰胺T衍生物

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2026-09-010

OAAI

DH_27, a right-half derivative of renieramycin T, induce apoptosis through inhibition of mTOR signaling for lung cancer suppression

DH_27，作为renieramycin T的右半部分衍生物，通过抑制mTOR信号通路诱导凋亡以抑制肺癌

Scientific Reports

IF3.9

2026-05-060

OAAI

Substituents introduction of methyl and methoxy functional groups on resveratrol stabilizes mTOR binding for autophagic cell death induction

在白藜芦醇上引入甲基和甲氧基官能团可稳定mTOR结合，从而诱导自噬性细胞死亡。

SCIENTIFIC REPORTS

IF3.9

2025-04-260

Molecular-level insights into the supramolecular gelation mechanism of urea derivative

对尿素衍生物超分子凝胶化机制的分子水平见解

NATURE COMMUNICATIONS

IF15.7

2025-04-220

A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2025-02-250

PRE

A New Renieramycin T Right-Half Analog as a Small Molecule Degrader of STAT3

MARINE DRUGS

IF5.4

2024-08-140

OAAI

Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines

SCIENTIFIC REPORTS

IF3.9

2023-12-060

OAAI

Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer

MARINE DRUGS

IF5.4

2023-11-302

OAAI

Light-Mediated Transformation of Renieramycins and Semisynthesis of 4′-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells

MARINE DRUGS

IF5.4

2023-07-130

OAAI

Simple Strategy for Benzo[g]chromene Synthesis via a Photochemical Intramolecular Cyclization Reaction

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2023-06-222

PRE

Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2023-06-039

OAAI

Transformation of Renieramycin M into Renieramycins T and S by Intramolecular Photoredox Reaction of 7-Methoxy-6-methyl-1,2,3,4-tetrahydroisoquinoline-5,8-dione Derivatives

JOURNAL OF NATURAL PRODUCTS

IF3.6

2023-01-117

PRE

Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer

MOLECULES

IF4.6

2022-11-2714

OAAI

Inhibition of BACE1 and amyloid β aggregation by polyketide from Streptomyces sp.

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2021-11-221

PREAI

Effect of Alkyl Chain Length of N-Alkyl-N′-(2-benzylphenyl)ureas on Gelation

CHEMISTRY-AN ASIAN JOURNAL

IF3.3

2021-06-019

PRE

Enzymatic Hydrolysis-Responsive Supramolecular Hydrogels Composed of Maltose-Coupled Amphiphilic Ureas

CHEMISTRY-AN ASIAN JOURNAL

IF3.3

2021-06-016

PRE

Urea Derivatives as Functional Molecules: Supramolecular Capsules, Supramolecular Polymers, Supramolecular Gels, Artificial Hosts, and Catalysts

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2021-01-2988

PREAI

Asymmetric Synthesis and Cytotoxicity Evaluation of Right-Half Models of Antitumor Renieramycin Marine Natural Products

MARINE DRUGS

IF5.4

2018-12-2011

OAAI

Stereoselective Total Synthesis of (-)-Renieramycin T

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2016-05-0334

PRE

Chemistry of Renieramycins. Part 14: Total Synthesis of Renieramycin I and Practical Synthesis of Cribrostatin 4 (Renieramycin H)

雷氏霉素的化学。第14部分: 肾霉素I的全合成和克布罗抑制素4 (肾霉素H) 的实际合成

MARINE DRUGS

IF5.4

2015-08-0614

OAAI

Masashi Yokoya

个人简介

教育背景

工作经历

荣誉奖项

研究方向